pfizer vaccine - Search News

News

FDA, Pfizer and Covid

FDA may revoke Pfizer COVID-19 vaccine authorization for kids under certain age

The Food and Drug Administration could pull Pfizer's coronavirus vaccine emergency authorization for children under age 5.

CNBC on MSN · 2d

FDA may pull authorization of Pfizer's Covid vaccine for children under 5, company says

The potential move to rescind authorization of Pfizer's vaccine could leave some kids in the U.S. with no available shots against Covid.

WFSB on MSN · 6h

FDA considering pulling authorization of Pfizer’s COVID-19 vaccine for healthy children under 5

The Food and Drug Administration is considering pulling its authorization of Pfizer’s COVID-19 vaccine for healthy children under five, and it could leave many kids unprotected from the virus.

‘It will be a little bit different this year.’ Here’s what you need to know about fall vaccines.

“We’ve stepped back into the world that we lived in before the [CDC’s vaccine advisory committee] was created,” said Dr.

TipRanks on MSN15h

Pfizer’s ABRYSVO Vaccine Study: A Potential Game-Changer for RSV Prevention in Older Adults

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a study titled Retrospective Study Evaluating ...

2don MSN

Trump previously called mRNA vaccines a 'medical miracle.' Now, RFK Jr. cut $500M in funding

The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be ...

CNET3y

With Pfizer vaccine boosters now available, what's next for Moderna and ...

The Pfizer vaccine is the first to receive FDA approval, while the Moderna and Johnson & Johnson vaccines are available under an emergency use authorization. For children ages 12 to 15, Pfizer's ...

NBC News4y

Pfizer, BioNTech ask FDA for full approval of Covid-19 vaccine

More 132 million doses of the Pfizer vaccine have been administered in the U.S., according to the CDC. The FDA is not required to call upon its VRBPAC members before giving full approval.

ABC News4y

Pfizer vaccine 95% effective in final analysis, plans to ... - ABC News

Pfizer and partner BioNTech announced their coronavirus vaccine is more than 95% effective in the final analysis of its massive Phase 3 trial on Wednesday, and has reached a key safety milestone ...

The Financial Express2d

Pfizer launches new single-shot pneumococcal vaccine in India — Are you in the high-risk group?

Pfizer has launched its 20-valent pneumococcal conjugate vaccine (PCV20) in India, offering single-dose protection against 20 ...

CNBCTV181d

Pfizer Q1 Results | Net profit surges 27%, margins improve

Pfizer's revenue grew 7.1% to ₹604 crore from ₹563 crore, while EBITDA increased 18.1% to ₹209.7 crore from ₹177.6 crore in ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results